Phibro Animal Health | PAHC - Loan Capital


Phibro Animal Health reported $597.68M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
ANI Pharmaceuticals USD 280.15M 5.84M Jun/2026
Aurora Cannabis CAD 18.13M 15.07M Mar/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Canopy Growth CAD 217.12M 7.87M Mar/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Henry Schein USD 2.3B 27M Jun/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Merck USD 51.08B 4.41B Jun/2026
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Pacira USD 363.12M 4.53M Jun/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 2.02B 1.01B Jun/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Zoetis USD 9.05B 3M Jun/2026